|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Holmes Scott A 1100 WINTER STREET WALTHAM, MA 02451 |
VP, Chief Accounting Officer |
Nancy R. Smith - attorney-in-fact | 12/17/2013 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | This total includes 2,250 previously unvested restricted stock units granted on September 12, 2011 and previously reported on Table II and 2,500 previously unvested restricted stock units granted on December 5, 2011 and previously reported on Table II. Portions of each of these awards (i.e. 750 and 1,250 restricted stock units, respectively, under each award) were scheduled to vest on September 12, 2013 and December 5, 2013, respectively. However, due to the black-out policies implemented by AMAG Pharmaceuticals, Inc. and certain tax laws, the shares underlying such restricted stock units were not delivered to the reported person until December 16, 2013, at which time 245 and 409 shares for each award, respectively, were withheld to satisfy the reporting person's tax obligations. Thus, after taking into account the delivery of the shares on December 16, 2013, this total includes an aggregate of 2,750 unvested restricted stock units previously reported in Table II. |